Implications and opportunities of applying QbD principles to analytical measurements

  • Mark Schweitzer
  • , Matthias Pohl
  • , Melissa Hanna-Brown
  • , Phil Nethercote
  • , Phil Borman
  • , Gordon Hansen
  • , Kevin Smith
  • , Jaqueline Larew
  • , John Carolan
  • , Joachim Ermer
  • , Pat Faulkner
  • , Christof Finkler
  • , Imogen Gill
  • , Oliver Grosche
  • , Jörg Hoffmann
  • , Alexander Lenhart
  • , Andy Rignall
  • , Torsten Sokoliess
  • , Guido Wegener

Research output: Contribution to journalReview articlepeer-review

Abstract

The benefits of adopting a quality-by-design approach to pharmaceutical products and processes are generally accepted by pharmaceutical manufacturers and regulatory agencies. To date, however, industry has focused primarily on product-development activities with little emphasis on developing a QbD approach for analytical methods. The authors present two concepts that have been created to improve robustness and facilitate continuous improvement m analytical methods and hope that the paper will stimulate further discussion regarding the application of QbD to analytical methods.

Original languageEnglish
Pages (from-to)52-59
Number of pages8
JournalPharmaceutical Technology
Volume34
Issue number2
Publication statusPublished - 2010

Cite this